期刊文献+

5-羟色胺转运体基因多态性与氟西汀疗效及副反应的关系 被引量:1

下载PDF
导出
摘要 目的探讨重性抑郁障碍(MDD)氟西汀疗效及不良反应与5-羟色胺转运体启动子区基因多态性(5-HTTLPR)的关系。方法选取符合美国精神障碍诊断与统计手册第4版(DSM-IV)重性抑郁障碍诊断标准的89例患者为研究对象。给予氟西汀治疗6周。利用聚合酶链反应(PCR)多态性技术检测5-HTTLPR多态性。结果不同基因型患者组之间治疗后HAMD总分减分率的差异有统计学意义(P<0.005),L/L基因型组的减分率高于另两种基因型组;有效组和无效组之间、有无恶心不良反应组之间的5-HTTL-PR的基因型和等位基因频率的差异均有统计学意义(P<0.05),L/L基因型组的疗效和恶心发生率高于另2组。结论5-HTTLPR基因多态性可能与氟西汀抗抑郁疗效及其恶心不良反应相关。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2008年第12期739-742,共4页 Chinese Journal of Nervous and Mental Diseases
基金 2004年度辽宁省教育厅基金(编号:2004D183)
  • 相关文献

参考文献13

  • 1Parsey RV, Hastings RS, Oquendo MA, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes[ J]. Am J Psychiatry, 2006, 163 ( 1 ) : 52 - 58.
  • 2Mackenzie A, Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer like properties in the mouse embryo [J]. Proc Natl Acad Sci USA, 1999, 96(26) : 15251 -15255.
  • 3Smeraldi E, Zanardi R, Benedetti F, et al. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine[J]. Mol Psychiatry, 1998, 3(6) : 508 -511.
  • 4Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression[J]. Neuropsychopharmacology, 2000, 23 (5) : 587 - 590.
  • 5Yu YW, Tsai SJ, Chen TJ, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders [ J ]. Mol Psychiatry, 2002, 7(10) : 1115 - 1119.
  • 6肖红,姚辉,郭苏婉,李箕君,吴如金.5-羟色胺转运蛋白基因多态性与抗抑郁药临床疗效的关系[J].中国临床药学杂志,2003,12(4):204-207. 被引量:9
  • 7Kim H, Lim SW, Kim S, et al. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression[J]. JAMA, 2006, 296(13): 1609- 1618.
  • 8潘集阳,马萍,梁华君,张继辉,徐伊.5-羟色胺转运体基因多态性与西酞普兰抗抑郁疗效的关系[J].中国神经精神疾病杂志,2007,33(9):557-559. 被引量:7
  • 9Takahashi H, Yoshida K, Ito K, et al. No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treament [ J ]. Eur Neuropsychopharmacol, 2002, 12 (5) : 477 -481.
  • 10Kato M, Fukuda T, Wskeno M, et al. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients [ J ]. Neuropsychobiology, 2006, 53 (4) : 186 - 195.

二级参考文献14

  • 1Heils A, Tenfel A. Petri S, et al. Allelic variation of human serotonin transporter gene expression[J]. J Neurochem, 1996,66(6):2621.
  • 2Smeraldi E, Zanardi R, Benedetti F, et al. Polymolphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine[J]. Mol Psychiatry, 1998,3(6) :508.
  • 3Zanardi R, Benedetti F, Di Bella D, et al. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene[J]. J Clin Psychopharmacol,2000,20(1) :105.
  • 4Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulayory region[J]. Science, 1996,274(5292) : 1527.
  • 5Rausch JL,Johnson ME,Fei YJ,et al.Initial conditions of serotonin transporter kinetics and genotype:Influence on SSRI treatment trial outcome.Biol Psychiatry,2002,51 (9):723.
  • 6Yu YW,Tsai SJ,Chen TJ,et al.Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.Mol Psychiatry,2002,7(10):1115.
  • 7Arias B,Catalan R,Gast?C,et al.Genetic variability in the promoter region of the serotonin transporter gene is associated with clinical remission of major depression after long term treatment with citalopram.Biol Psychiatry,2001,2 (suppl.1):9.
  • 8Arias B,Catalan R,Gast?C,et al.5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.J Clinical psychopharmacology,2003,23 (6):563.
  • 9Kim DK,Lim SW,Lee S,et al.Serotonin transporter gene polymorphism and antidepressant response.NeuroReport,2000,11 (1):215.
  • 10Yoshida K,Ito K,Sato K,et al.Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.Progress in Neuro-Psychopharmacology and Biological Psychiatry,2002,26(2):383.

共引文献12

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部